Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation
Authors:
- Rainer SchulzRSRainer Schulz
- Gerd HeuschGHGerd Heusch
- 1 March 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 24 (Suppl 1) , S123-S129
Abstract
Cerebral ischaemia-reperfusion injury is associated with an inflammatory response, with contributions from leucocytes and microglia. Formation of free radicals and nitric oxide contributes to the development of cerebral infarction and of the neurological deficit that follows transient focal ischaemia. The circulating and cerebral renin-angiotensin systems contribute, via stimulation of the angiotensin II (Ang II) types 1 (AT1) and 2 receptors, to the initiation or progression of inflammatory processes, and blockade of AT1-receptors prevents irreversible tissue injury and improves outcome from stroke in animal experiments. Such cerebral protection can be achieved even when treatment is initiated hours after established reperfusion. Blockade of AT1-receptors also reduces the incidence of stroke and cardiovascular mortality associated with stroke in patients; however, the mechanisms underlying the prevention of stroke by AT1-receptor blockade in patients remain to be elucidated. In this review we summarize the existing experimental and clinical data demonstrating that the renin-angiotensin system contributes to the inflammation and subsequent irreversible injury after cerebral ischaemia-reperfusion. We conclude that AT1-receptor blockade reduces cerebral ischaemia-reperfusion injury in part by attenuating inflammatory processes.Keywords
This publication has 86 references indexed in Scilit:
- Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic OpportunitiesCellular and Molecular Neurobiology, 2005
- Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive RatsStroke, 2005
- RETRACTED: Prospects for the future: the role of free radicals in the treatment of strokeFree Radical Biology and Medicine, 2005
- The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on losartanCurrent Medical Research and Opinion, 2004
- A putative placebo comparison of the SCOPE and LIFE trialsJournal of the Renin-Angiotensin-Aldosterone System, 2004
- Delayed Treatment of Ischemia/Reperfusion Brain InjuryStroke, 2004
- The ACCESS StudyStroke, 2003
- Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT 1 AntagonistStroke, 2002
- Angiotensin II AT 1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive RatsStroke, 2000
- Inducible Nitric Oxide Synthase Gene Expression in Vascular Cells After Transient Focal Cerebral IschemiaStroke, 1996